シングルセルオミクスの世界市場

シングルセルオミクスの世界市場は2030年までに43億米ドルに達する見込み

2024年に18億米ドルと推定されるシングルセルオミクスの世界市場は、分析期間2024-2030年にCAGR 15.4%で成長し、2030年には43億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるシングルセルゲノミクスは、CAGR 17.8%を記録し、分析期間終了までに21億米ドルに達すると予測されます。シングルセル・トランスクリプトミクス分野の成長率は、分析期間中CAGR13.3%と推定されます。

米国市場は4億9,880万米ドルと推定、中国はCAGR20.9％で成長予測

米国のシングルセルオミクス市場は、2024年には4億9,880万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを20.9%として、2030年までに予測市場規模9億5,880万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ11.2％と14.0％と予測されています。欧州では、ドイツがCAGR約12.3%で成長すると予測されています。

世界のシングルセルオミクス市場- 主要動向と促進要因のまとめ

シングルセルオミクスはどのように生物医学研究を変革するか？プレシジョン医療と疾患理解における役割を探る

シングルセルオミクスの分野は、科学者が大量の細胞集団からのシグナルを平均化するのではなく、個々の細胞の分子的および遺伝的特性を分析することを可能にすることにより、生物医学研究に革命をもたらしました。このアプローチにより、細胞の不均一性に関するこれまでにない洞察が得られ、研究者は希少な細胞集団の研究、疾患の進行の追跡、新たな治療標的の発見が可能になります。シングルセルオミクスは、シングルセルゲノミクス、トランスクリプトミクス、プロテオミクス、メタボロミクスなど複数の分野を包含し、これらすべてが細胞機能のより包括的な理解に寄与します。これらの技術は、細胞の多様性が疾病メカニズムにおいて重要な役割を果たす腫瘍学、免疫学、神経科学、再生医療において特に有用であることが証明されています。細胞の高解像度プロファイリングを可能にすることで、シングルセルオミクスは研究者がより的を絞った治療法を開発し、精密医療への道を開く手助けをしています。個別化ヘルスケアに対する科学的関心が高まるにつれ、高度なシングルセル解析ツールに対する需要は拡大し続け、市場の成長を後押ししています。

シングルセルオミクスを強化する技術的進歩とは？データ解析と機器におけるイノベーションの検証

シーケンス技術、マイクロ流体工学、バイオインフォマティクスにおける最近の進歩は、シングルセルオミクス研究の効率性と拡張性を大幅に向上させています。次世代シーケンス（NGS）プラットフォームは、液滴ベースやマイクロ流体による細胞分離技術と組み合わせることで、ハイスループットな単一細胞解析を可能にし、数千の細胞を同時に処理することを可能にしています。人工知能（AI）と機械学習（ML）もまた、データ解釈を強化する上で重要な役割を果たし、研究者は膨大で複雑なデータセットから意味のある生物学的洞察を引き出すことができるようになりました。さらに、ゲノミクス、プロテオミクス、メタボロミクスのデータを一緒に解析するマルチオミクス・アプローチの統合により、細胞の挙動をより全体的に捉えることができるようになりました。このような技術革新により、調査技術の再現性、感度、費用対効果が改善され、学術研究、臨床研究のいずれの場においても、より利用しやすいものとなっています。テクノロジーが進化し続けるにつれ、シングルセル解析ツールはさらに洗練され、創薬や疾患モデリングへの応用が拡大すると期待されています。

シングルセルオミクスの導入を阻む課題とは？コスト、複雑さ、データ解釈の問題への対処

シングルセルオミクスは、その革新的な可能性にもかかわらず、高いコスト、技術的な複雑さ、データ解析の限界など、いくつかの課題に直面しています。シングルセルシーケンスやマルチオミクスプロファイリングに必要な装置や試薬は依然として高価であり、リソースに制約のある研究環境での利用を制限しています。さらに、バイアスやアーチファクトを導入することなく単一細胞を分離・処理するために必要な技術的専門知識は、多くの研究室にとって課題となっています。シングルセルオミクス研究によって生成される膨大な量のデータは、計算上の課題ももたらし、効率的な保存と解析のために高度なバイオインフォマティクスツールとクラウドベースのプラットフォームが必要となります。実験プロトコールとデータ解釈の標準化は、技術のばらつきが異なる研究間で一貫性のない結果をもたらす可能性があるため、依然として重要な課題です。このような課題に対処するためには、費用対効果の高い技術への継続的な投資、計算ツールの改善、そして研究の信頼性と再現性を確保するための標準化されたワークフローが必要です。

何がシングルセルオミクス市場の成長を促進しているのか？主な拡大要因と業界動向の特定

シングルセルオミクス市場の成長は、精密医療研究への資金提供の増加、シーケンス技術の進歩、がんや神経変性疾患などの複雑な疾患の有病率の上昇など、いくつかの要因によってもたらされています。政府や民間組織は、生物医学的発見や医薬品開発を加速するため、シングルセル解析ツールに多額の投資を行っています。さらに、疾患の早期発見やバイオマーカー探索のニーズの高まりが、臨床研究や診断におけるシングルセルオミクスの採用を後押ししています。シングルセルデータ解析におけるAIとクラウドコンピューティングの統合により、ワークフローはさらに合理化され、これらの技術はより幅広い用途で利用できるようになりました。さらに、製薬会社は標的薬剤開発や個別化治療戦略にシングルセルオミクスを活用し、市場の商業的可能性を拡大しています。技術の進歩が続き、精密ヘルスケアへの需要が高まる中、シングルセルオミクス市場は大幅な成長を遂げ、疾病の調査方法や細胞レベルでの治療方法に革命をもたらすでしょう。

セグメント

製品タイプ（シングルセルゲノミクス、シングルセルトランスクリプトミクス、シングルセルプロテオミクス、シングルセルメタボロミクス）、用途（腫瘍学、細胞生物学、神経学、免疫学）、最終用途（製薬・バイオテクノロジー企業、学術・研究機関、病院・診断研究所、その他）

調査対象企業の例

• 10x Genomics
• Agilent Technologies Inc.
• ANGLE plc
• Becton, Dickinson and Company（BD）
• BGI Genomics Co. Ltd
• Bio-Rad Laboratories, Inc.
• Bio-Techne
• Celldom, Inc.
• CELLENION
• CYTENA GmbH
• Danaher Corporation
• Dolomite Bio
• Epicypher Inc.
• Fluidigm Corporation
• Fluxion Biosciences
• Illumina, Inc.
• Miltenyi Biotec B.V. & Co. KG
• Mission Bio, Inc.
• NanoString Technologies, Inc.
• Pacific Biosciences
• PerkinElmer Inc.
• Proteona
• QIAGEN N.V.
• Scipio Bioscience
• Single Cell Discoveries
• Singleron Biotechnologies
• Singulomics
• Standard BioTools Inc.
• Takara Bio Group
• Thermo Fisher Scientific

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Single-Cell Omics Market to Reach US$4.3 Billion by 2030

The global market for Single-Cell Omics estimated at US$1.8 Billion in the year 2024, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2024-2030. Single-Cell Genomics, one of the segments analyzed in the report, is expected to record a 17.8% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Single-Cell Transcriptomics segment is estimated at 13.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$498.8 Million While China is Forecast to Grow at 20.9% CAGR

The Single-Cell Omics market in the U.S. is estimated at US$498.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$958.8 Million by the year 2030 trailing a CAGR of 20.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.2% and 14.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.

Global Single-Cell Omics Market - Key Trends & Drivers Summarized

How Is Single-Cell Omics Transforming Biomedical Research? Exploring Its Role in Precision Medicine and Disease Understanding

The field of single-cell omics has revolutionized biomedical research by enabling scientists to analyze the molecular and genetic characteristics of individual cells, rather than averaging signals from bulk cell populations. This approach provides unprecedented insights into cellular heterogeneity, allowing researchers to study rare cell populations, track disease progression, and uncover new therapeutic targets. Single-cell omics encompasses multiple disciplines, including single-cell genomics, transcriptomics, proteomics, and metabolomics, all of which contribute to a more comprehensive understanding of cellular functions. These techniques have proven particularly valuable in oncology, immunology, neuroscience, and regenerative medicine, where cellular diversity plays a critical role in disease mechanisms. By enabling high-resolution profiling of cells, single-cell omics is helping researchers develop more targeted therapies, paving the way for precision medicine. As scientific interest in personalized healthcare grows, the demand for advanced single-cell analysis tools continues to expand, fueling market growth.

What Technological Advancements Are Enhancing Single-Cell Omics? Examining Innovations in Data Analysis and Instrumentation

Recent advancements in sequencing technologies, microfluidics, and bioinformatics have significantly improved the efficiency and scalability of single-cell omics studies. Next-generation sequencing (NGS) platforms, combined with droplet-based and microfluidic cell isolation techniques, have enabled high-throughput single-cell analysis, making it possible to process thousands of cells simultaneously. Artificial intelligence (AI) and machine learning (ML) have also played a critical role in enhancing data interpretation, allowing researchers to extract meaningful biological insights from vast and complex datasets. Additionally, the integration of multi-omics approaches, where genomics, proteomics, and metabolomics data are analyzed together, has provided a more holistic view of cellular behavior. These innovations have improved the reproducibility, sensitivity, and cost-effectiveness of single-cell omics technologies, making them more accessible for both academic and clinical research settings. As technology continues to evolve, single-cell analysis tools are expected to become even more sophisticated, expanding their applications in drug discovery and disease modeling.

What Challenges Are Hindering the Adoption of Single-Cell Omics? Addressing Cost, Complexity, and Data Interpretation Issues

Despite its transformative potential, the widespread adoption of single-cell omics faces several challenges, including high costs, technical complexity, and data analysis limitations. The instrumentation and reagents required for single-cell sequencing and multi-omics profiling remain expensive, limiting their accessibility in resource-constrained research environments. Additionally, the technical expertise needed to isolate and process single cells without introducing bias or artifacts poses a challenge for many laboratories. The massive volume of data generated by single-cell omics studies also presents computational challenges, requiring advanced bioinformatics tools and cloud-based platforms for efficient storage and analysis. Standardization across experimental protocols and data interpretation remains a key issue, as variability in techniques can lead to inconsistent results across different studies. Addressing these challenges requires continued investment in cost-effective technologies, improved computational tools, and standardized workflows to ensure the reliability and reproducibility of single-cell omics research.

What’s Driving the Growth of the Single-Cell Omics Market? Identifying Key Expansion Factors and Industry Trends

The growth in the single-cell omics market is driven by several factors, including increasing funding for precision medicine research, advancements in sequencing technology, and the rising prevalence of complex diseases such as cancer and neurodegenerative disorders. Governments and private organizations are heavily investing in single-cell analysis tools to accelerate biomedical discoveries and drug development. Additionally, the growing need for early disease detection and biomarker discovery has boosted the adoption of single-cell omics in clinical research and diagnostics. The integration of AI and cloud computing in single-cell data analysis has further streamlined workflows, making these technologies more accessible for a broader range of applications. Moreover, pharmaceutical companies are leveraging single-cell omics for targeted drug development and personalized treatment strategies, expanding the commercial potential of the market. With continued technological advancements and increasing demand for precision healthcare, the single-cell omics market is poised for substantial growth, revolutionizing how diseases are studied and treated at the cellular level.

SCOPE OF STUDY:

The report analyzes the Single-Cell Omics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics); Application (Oncology, Cell Biology, Neurology, Immunology); End-Use (Pharma & Biotech Companies, Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

• 10x Genomics
• Agilent Technologies Inc.
• ANGLE plc
• Becton, Dickinson and Company (BD)
• BGI Genomics Co. Ltd
• Bio-Rad Laboratories, Inc.
• Bio-Techne
• Celldom, Inc.
• CELLENION
• CYTENA GmbH
• Danaher Corporation
• Dolomite Bio
• Epicypher Inc.
• Fluidigm Corporation
• Fluxion Biosciences
• Illumina, Inc.
• Miltenyi Biotec B.V. & Co. KG
• Mission Bio, Inc.
• NanoString Technologies, Inc.
• Pacific Biosciences
• PerkinElmer Inc.
• Proteona
• QIAGEN N.V.
• Scipio Bioscience
• Single Cell Discoveries
• Singleron Biotechnologies
• Singulomics
• Standard BioTools Inc.
• Takara Bio Group
• Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Single-Cell Omics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Focus on Cellular Heterogeneity in Disease Biology Throws the Spotlight on Single-cell Omics Technologies
  • Expansion of Oncology and Immunotherapy Research Drives Demand for High-Resolution Molecular Profiling Tools
  • OEM Innovation in Microfluidic and Droplet-Based Platforms Accelerates Throughput and Cell Recovery Rates
  • Growth in Spatial Transcriptomics and Epigenomics Techniques Spurs Multi-Omics Integration Across Modalities
  • OEM Development of Multiomic Assay Kits and Instrument Bundles Enhances Workflow Simplification
  • Regulatory Support for Precision Medicine and Companion Diagnostics Drives Clinical Application of Single-cell Omics
  • OEM Collaboration With Academic Research Institutes Expands Access to Cell Atlas and Reference Databases
  • Rising Adoption in Neurobiology, Developmental Biology, and Stem Cell Research Broadens Scientific Utility
  • OEM Investment in Single-cell Data Analysis Software and AI-Based Interpretation Platforms Enhances Biological Insight
  • Growth in Single-cell CRISPR Screening and Perturb-seq Expands Functional Genomics Capabilities
  • OEM Emphasis on Scalable, Automation-Compatible Platforms Supports Use in High-Throughput Labs
  • Expansion of National Genomic Initiatives Globally Boosts Infrastructure Funding for Single-cell Research
  • OEM Development of Sample Preservation and Cell Viability Enhancers Increases Usable Input Quality
  • Increasing Demand for Cell-to-Cell Variability Assessment in Drug Discovery Propels Platform Commercialization
  • OEM Strategies for Cost Reduction and Multiplexing Drive Affordability for Broader Lab Adoption
  • Rising Focus on Tumor Microenvironment Characterization Accelerates Demand for Single-cell Immune Profiling
  • OEM Integration of Cell Sorting and Isolation Capabilities Within Single Workflow Enhances Operational Efficiency
  • Growth in Biobanking and Longitudinal Studies Increases Need for Standardized Single-cell Assay Reproducibility
  • OEM Expansion Into Single-nucleus and FFPE-Compatible Protocols Broadens Clinical Sample Applicability
  • Focus on End-to-End Omics Solutions and Vendor Partnerships Drives Ecosystem Consolidation in Single-cell Market
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Single-Cell Omics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Single-Cell Omics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Single-Cell Omics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Single-Cell Omics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Single-Cell Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Single-Cell Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Single-Cell Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Single-Cell Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Single-Cell Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Single-Cell Transcriptomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Single-Cell Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Single-Cell Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Single-Cell Proteomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Single-Cell Metabolomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Single-Cell Metabolomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Single-Cell Metabolomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Academic & Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Academic & Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Academic & Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Cell Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• JAPAN
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• CHINA
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• EUROPE
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Single-Cell Omics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Single-Cell Omics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Single-Cell Omics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• FRANCE
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• GERMANY
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Single-Cell Omics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Single-Cell Omics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• INDIA
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Single-Cell Omics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Single-Cell Omics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Single-Cell Omics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Single-Cell Omics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030
• AFRICA
  • Single-Cell Omics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Single-Cell Omics by Product Type - Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Single-Cell Omics by Product Type - Percentage Breakdown of Value Sales for Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics and Single-Cell Metabolomics for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Single-Cell Omics by End-Use - Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Single-Cell Omics by End-Use - Percentage Breakdown of Value Sales for Academic & Research Organizations, Hospital & Diagnostic Laboratories, Others and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Single-Cell Omics by Application - Oncology, Cell Biology, Neurology and Immunology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Single-Cell Omics by Application - Percentage Breakdown of Value Sales for Oncology, Cell Biology, Neurology and Immunology for the Years 2015, 2025 & 2030

IV. COMPETITION